Measuring meaningful outcomes for adolescent idiopathic scoliosis: a narrative review and critical appraisal of the Scoliosis Research Society-22 revised (SRS-22r) instrument

衡量青少年特发性脊柱侧弯的有效结果:脊柱侧弯研究协会-22修订版(SRS-22r)工具的叙述性综述和批判性评价

阅读:1

Abstract

BACKGROUND AND OBJECTIVE: The Scoliosis Research Society-22 revised questionnaire (SRS-22r) is the most widely used patient-reported outcome measure (PROM) to evaluate health-related quality of life (HRQL) for patients with adolescent idiopathic scoliosis (AIS). Here, we seek to critically appraise the development process and psychometric properties of the SRS-22r. METHODS: We evaluated the item generation, item reduction, sensibility and measurement properties including reliability, validity and responsiveness of the SRS-22r. To accomplish this, we examined available literature describing psychometric properties of the SRS-22r and summarized the findings in a narrative review format. KEY CONTENT AND FINDINGS: The SRS-22r represents a multi-dimensional outcome measure that demonstrates generally appropriate responsiveness to outcomes after surgical AIS deformity correction. Despite its strengths, several limitations were identified, including (I) absence of a conceptual framework for HRQL in AIS; (II) lack of direct patient involvement during development of the instrument; (III) minimal evidence of evaluation of the interpretation, appropriateness and importance, comprehensiveness of the items by adolescents; and (IV) the inclusion of a satisfaction with treatment (surgery) domain within a HRQL instrument. Though the SRS-22r is responsive to change after surgical intervention, its ability to discriminate between mild and moderate scoliosis remains limited. CONCLUSIONS: Our findings characterize the strengths and limitations of the SRS-22r. An ideal AIS HRQL measure should be guided by a conceptual framework informed by, and aligned with the priorities and goals of adolescents with idiopathic scoliosis based on their lived experience, complemented by parental perspectives and input from clinician experts with an understanding AIS management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。